Search

The Brown Arrhythmia Symposium is designed to provide cardiac electrophysiologists, cardiologists, cardiovascular surgeons, emergency medicine physicians, internists and associated professionals with a state-of-the-art update on the clinical diagnosis, evaluation and management of cardiac rhythm disorders.

Attendees of the symposium will gain an understanding of new therapies in cardiac diagnostics and cardiac ablation, surgical intervention, and cardiac device management for patients with congestive heart failure, atrial fibrillation, and ventricular tachycardia.

Specialized content has been specially designed for associated professionals and advanced practitioners involved in the management of patients with cardiac rhythm disorders. The program will uniquely highlight clinical controversies in a clinical case format.

WASHINGTON, DC – The American College of Cardiology (ACC), Heart Failure Society of America (HFSA), Heart Rhythm Society (HRS) and Society for Cardiovascular Angiography and Interventions (SCAI) have announced a partnership to develop new modules to help subspecialty cardiologists potentially meet collaborative maintenance pathway requirements equivalent to satisfying the ABIM’s current 10-year MOC examination.

The Western Atrial Fibrillation (WAF) Symposium assembles key global thought leaders for a collaborative discussion regarding the latest advancement in atrial fibrillation research and treatment. WAF features a distinguished faculty of physicians and researchers from 10 countries and 44 renowned biomedical centers across the United States. WAF speakers and panels discuss topics such as the electrical mechanisms of atrial fibrillation, image processing to improve AF management, AF and heart failure, MRI-guided ablation, improvements in patient care and AF outcomes, microscopy to characterize fibrosis, drug therapy, ECG monitoring, and technical advancements in the field of atrial fibrillation.

Stanford Biodesign New Arrhythmia Technologies Retreat will highlight, in a single day, the latest and emerging technologies in arrhythmia therapy. The Retreat is designed to serve as an expert forum of 50 key thought leaders and innovators to share their ideas about new and emerging technologies in arrhythmia management and diagnosis. Physicians and scientists will be asked to give brief talks about the emerging developments in their field, the key needs in cardiac arrhythmias in their area of expertise, and the likely solutions in the next 5 years. A speed-dating format will be used to highlight start-up companies in the field. Start-up innovators will be given the opportunity to speak about the start-up and medical device innovation process.

March 18, 2018—This expert consensus statement, based on a thorough review of the medical literature regarding cognitive function in arrhythmias, is intended to describe the impact of different types of arrhythmias on cognitive function, to highlight possible risk markers for cognitive decline, and to formulate implications for clinical practice regarding follow-up methods, prevention, and treatment strategies. The objective is to raise awareness of cognitive function among physicians treating patients with arrhythmias and to provide them with practical proposals that may lead to improvement of patient care in this regard.